Da Jiang

No. 12, Jiankang Road
Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Global Path Planning Methods Based on the Relationship Between Traversability Capability and Terrain Matching.

Global Path Planning Methods Based on the Relationship Between Traversability Capability and Terrain Matching.

Journal: Sensors (Basel, Switzerland)

Published: January 08, 2026

Online Mapping from Weight Matching Odometry and Highly Dynamic Point Cloud Filtering via Pseudo-Occupancy Grid.

Online Mapping from Weight Matching Odometry and Highly Dynamic Point Cloud Filtering via Pseudo-Occupancy Grid.

Journal: Sensors (Basel, Switzerland)

Published: September 29, 2025

Integration of Vehicle-Terrain Interaction and Fuzzy Cost Adaptation for Robust Path Planning.

Integration of Vehicle-Terrain Interaction and Fuzzy Cost Adaptation for Robust Path Planning.

Journal: Sensors (Basel, Switzerland)

Published: June 24, 2025

Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study.

Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study.

Journal: European journal of medical research

Published: May 06, 2025

Anti-PD-L1 envafolimab combined with anti-VEGF suvemcitug in pretreated solid tumors and hepatocellular carcinoma: an open-label phase II study with safety run-in stage.

Anti-PD-L1 envafolimab combined with anti-VEGF suvemcitug in pretreated solid tumors and hepatocellular carcinoma: an open-label phase II study with safety run-in stage.

Journal: Investigational new drugs

Published: September 24, 2024

Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Journal: Thoracic cancer

Published: November 27, 2023

An Integrated Autonomous Dynamic Navigation Approach toward a Composite Air-Ground Risk Construction Scenario.

An Integrated Autonomous Dynamic Navigation Approach toward a Composite Air-Ground Risk Construction Scenario.

Journal: Sensors (Basel, Switzerland)

Published: November 07, 2023

Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.

Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.

Journal: Thoracic cancer

Published: October 25, 2023

Long-term response to camrelizumab in a pretreated metastatic mixed testicular germ-cell tumor patient with co-mutations in DNA damage-repair genes.

Long-term response to camrelizumab in a pretreated metastatic mixed testicular germ-cell tumor patient with co-mutations in DNA damage-repair genes.

Journal: Immunotherapy

Published: January 17, 2023

Involvement of ZDHHC9 in lung adenocarcinoma: regulation of PD-L1 stability via palmitoylation.

Involvement of ZDHHC9 in lung adenocarcinoma: regulation of PD-L1 stability via palmitoylation.

Journal: In vitro cellular & developmental biology. Animal

Published: November 07, 2022

Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial.

Correction To: Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial.

Journal: British journal of cancer

Published: November 03, 2022

Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer.

Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer.

Journal: Nature communications

Published: November 02, 2022

Showing 1-12 of 48

Last Updated: 09/26/2026